Saturday, February 22
Shadow

Author: GHealth News

WHO prequalifies the first vaccine against mpox

WHO prequalifies the first vaccine against mpox

Communicable Diseases
GHealth News - The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. The prequalification approval is expected to facilitate timely and increased access to this vital product in communities with urgent need, to reduce transmission and help contain the outbreak. WHO’s assessment for prequalification is based on information submitted by the manufacturer, Bavarian Nordic A/S, and review by the European Medicines Agency, the regulatory agency of record for this vaccine. “This first prequalification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,” said WHO Director-General Dr Tedros Adhanom Ghebre...
A new global health emergency: What is mpox, where are the outbreaks and will the virus spread?

A new global health emergency: What is mpox, where are the outbreaks and will the virus spread?

Communicable Diseases
By  MARIA CHENG The World Health Organization declared Wednesday that the increasing spread of mpox in Africa is a global health emergency, warning the virus might ultimately spill across international borders. The announcement by WHO director-general Tedros Adhanom Ghebreyesus came after a meeting of the U.N. health agency’s emergency committee. The Africa Centers for Disease Control and Prevention declared mpox a public health emergency on the continent on Tuesday. WHO said there have been more than 14,000 cases and 524 deaths in Africa this year, which already exceed last year’s figures. So far, more than 96% of all cases and deaths are in a single country — Congo. Scientists are concerned by the spread of a new version of the disease there that might be more easily tra...
WHO teams up with IOC and France to support healthy Paris Olympics

WHO teams up with IOC and France to support healthy Paris Olympics

Global Health
GHealth News - The World Health Organization is taking part in the Paris Olympics in multiple fields, supporting the International Olympic Committee (IOC) and France to help make the world’s leading sport spectacle, which officially starts this Friday, healthy and safe for spectators and athletes alike. “Just as athletes and fans around the world have been preparing for the Paris Olympics, WHO has been working with the IOC and the Government of France to make sure these Games are healthy and safe for everyone involved,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “From promoting physical activity to protecting people from a range of health threats, WHO has been proud to play its part in making the Paris Olympics a success.” WHO and the IOC, close partners through a memor...
Why Is Antimicrobial Resistance Not Getting Much Attention from Biopharma?

Why Is Antimicrobial Resistance Not Getting Much Attention from Biopharma?

AMR
By Ben Hargreaves The COVID-19 pandemic showed what can be done when government and industry worldwide recognizes a grave threat to public health. Coordinated action allowed the biopharma sector to quickly develop and deploy vaccines. However, the same urgency is not being seen for an even larger risk to public health: the rise of antimicrobial resistance (AMR). The creation of antibiotics stands as one of the greatest medical breakthroughs in history, saving hundreds of millions of lives, and now halting the rise of AMR has emerged as a global health imperative. The World Health Organization (WHO) has declared that AMR is one of the top global public health and development threats, with nearly 5 million associated deaths per year. If left unchecked, this fig...
WHO and partners launch global dashboard on child health

WHO and partners launch global dashboard on child health

Global Health
Shedding light on issues ranging from childhood survival to educational attainment and exposure to violence, a global dashboard will help policymakers, the health community and the public track progress on some of the critical factors influencing children’s health and their futures. Currently, 4.9 million children aged under 5 years die every year, with nearly half of these babies in their very first month of life. Based on current trends, 59 countries will miss the United Nations’ Sustainable Development Goal (SDG) target for under-5 deaths. During the 77th World Health Assembly, noting these statistics, countries committed to accelerate actions to improve maternal and child health and survival (Resolution WHA 77/5). Data is critical for these efforts, helpi...
Scientists have discovered a 50,000-year-old herpes virus

Scientists have discovered a 50,000-year-old herpes virus

Communicable Diseases
Less than a decade ago, the American anthropologist James C Scott described infectious diseases as the “loudest silence” in the prehistoric archaeological record. Epidemics must have devastated human societies in the distant past and changed the course of history, but, Scott lamented, the artefacts left behind reveal nothing about them. Over the last few years, the silence has been shattered by pioneering research that analyses microbial DNA extracted from very old human skeletons. The latest example of this is a groundbreaking study that identified three viruses in 50,000-year-old Neanderthal bones. These pathogens still afflict modern humans: adenovirus, herpesvirus and papillomavirus cause the common cold, cold sores, and genital warts and cancer, respectively. Th...
Global health heavyweights team up for climate, disease funding

Global health heavyweights team up for climate, disease funding

Global Health
GHealth News - Three of the biggest global health funders have joined forces for the first time in a $300 million partnership aimed at tackling the linked impacts of climate change, malnutrition, and infectious diseases and antimicrobial resistance. The Novo Nordisk Foundation, Wellcome and the Bill & Melinda Gates Foundation announced the research partnership, focused particularly on finding affordable solutions for people in low and middle-income countries, in Denmark on Monday. Each will put $100 million into the three-year initiative. A key aim is to "break down barriers between often isolated areas of research", said Mads Krogsgaard Thomsen, chief executive officer of the Novo Nordisk Foundation. For example, COVID-19 showed that obesity can be a risk factor for the se...
COVID-19 Treatment Guidelines Show Great Global Variance

COVID-19 Treatment Guidelines Show Great Global Variance

COVID19
There is significant global variation in COVID-19 treatment recommendations and disease severity stratifications, according to a study published online April 22 in BMJ Global Health. Mia Cokljat, M.B.Ch.B., from the University of Oxford in the United Kingdom, and colleagues compared the COVID-19 treatment guidelines of each World Health Organization (WHO) member state to the WHO COVID-19 therapeutic guidelines. The analysis included COVID-19 therapeutic national guidelines for 109 of the 194 WHO member states. The researchers found considerable variation in guidelines and in disease severity stratifications. There were also substantial differences in therapeutic recommendations in many national guidelines versus the WHO guidelines. In late 2022, 93 percent of national guidelines...
US FDA approves Merck’s therapy for rare lung condition

US FDA approves Merck’s therapy for rare lung condition

NCDs
GHealth News - The U.S. Food and Drug Administration on Tuesday approved Merck's (MRK.N), opens new tab treatment for adults with high blood pressure due to constriction of lung arteries, adding another potential blockbuster drug to the pharmaceutical giant's portfolio. Shares of Merck were up more than 4% in extended trading. The therapy, branded Winrevair, is approved for treating pulmonary arterial hypertension (PAH), which affects about 40,000 people in the United States. "We look forward to making a significant difference for these patients that are left with a disease where the five year mortality is 43%," Jannie Oosthuizen, president of Merck's U.S. Human Health business, told Reuters. Winrevair will carry a list price of $14,000 per vial, Oosthuizen said. Acco...
U.N. Weather Agency Issues ‘Red Alert’ on Climate Change

U.N. Weather Agency Issues ‘Red Alert’ on Climate Change

Climate Change
GHealth News - The U.N. weather agency is sounding a “red alert” about global warming, citing record-smashing increases last year in greenhouse gases, land and water temperatures and melting of glaciers and sea ice, and is warning that the world's efforts to reverse the trend have been inadequate. The World Meteorological Organization said there is a “high probability” that 2024 will be another record-hot year. The Geneva-based agency, in a “State of the Global Climate” report released Tuesday, ratcheted up concerns that a much-vaunted climate goal is increasingly in jeopardy: That the world can unite to limit planetary warming to no more than 1.5 degrees Celsius (2.7 degrees Fahrenheit) from pre-industrial levels. “Never have we been so close – albeit on a temporary basis at the ...